Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02499835
Title Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Age Groups: adult
Covered Countries USA

No variant requirements are available.